Eurobio Scientific Société anonyme
Eurobio Scientific Société anonyme operates in various business sectors.
Eurobio Scientific Société anonyme (E8TN) - Total Assets
Latest total assets as of December 2023: €316.33 Million EUR
Based on the latest financial reports, Eurobio Scientific Société anonyme (E8TN) holds total assets worth €316.33 Million EUR as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Eurobio Scientific Société anonyme - Total Assets Trend (2018–2023)
This chart illustrates how Eurobio Scientific Société anonyme’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Eurobio Scientific Société anonyme - Asset Composition Analysis
Current Asset Composition (December 2023)
Eurobio Scientific Société anonyme's total assets of €316.33 Million consist of 45.5% current assets and 54.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 15.6% |
| Accounts Receivable | €26.94 Million | 8.5% |
| Inventory | €21.45 Million | 6.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €35.42 Million | 11.2% |
| Goodwill | €117.71 Million | 37.2% |
Asset Composition Trend (2018–2023)
This chart illustrates how Eurobio Scientific Société anonyme's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eurobio Scientific Société anonyme's current assets represent 45.5% of total assets in 2023, a decrease from 45.6% in 2018.
- Cash Position: Cash and equivalents constituted 15.6% of total assets in 2023, up from 14.2% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 44.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 37.2% of total assets.
Eurobio Scientific Société anonyme Competitors by Total Assets
Key competitors of Eurobio Scientific Société anonyme based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Eurobio Scientific Société anonyme - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Eurobio Scientific Société anonyme generates 0.41x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Eurobio Scientific Société anonyme generates $ 1.53 in net profit.
Eurobio Scientific Société anonyme - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.72 | 2.59 | 4.81 |
| Quick Ratio | 2.32 | 2.22 | 4.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €91.03 Million | € 91.37 Million | € 137.49 Million |
Eurobio Scientific Société anonyme - Advanced Valuation Insights
This section examines the relationship between Eurobio Scientific Société anonyme's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.4% |
| Total Assets | €316.33 Million |
| Market Capitalization | $241.28K USD |
Valuation Analysis
Below Book Valuation: The market values Eurobio Scientific Société anonyme's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Eurobio Scientific Société anonyme's assets decreased by 4.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Eurobio Scientific Société anonyme (2018–2023)
The table below shows the annual total assets of Eurobio Scientific Société anonyme from 2018 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €316.33 Million | -4.35% |
| 2022-12-31 | €330.73 Million | +57.59% |
| 2021-12-31 | €209.87 Million | +21.80% |
| 2020-12-31 | €172.30 Million | +112.70% |
| 2019-12-31 | €81.01 Million | +15.89% |
| 2018-12-31 | €69.90 Million | -- |